We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 26

District Court Dismisses Tying and Bundling Claims, Holding that Medical-Surgical Distributor Failed to Show Market Power or Injury to Competition
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • April 12 2016

The federal district court for the District of Kansas recently dismissed claims by a medical products distributor that two of its competitors


U.S. Justice Department Requires Restructuring of Transaction Involving Foreign Entities to Address Section 8 Interlocking Directorates Concern
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • July 19 2016

On July 14, 2016, the United States Department of Justice announced that it had concerns that a transaction involving two foreign electronic trading


FTC announces lower Hart-Scott-Rodino thresholds
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 21 2010

The Federal Trade Commission (the "FTC") has revised the jurisdictional and filing fee thresholds of the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the "HSR Act") and the Pre-merger Notification Rules (the "Rules"


Ninth Circuit courts reject antitrust “bundling” claims in two recent cases
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • November 16 2009

In two recent cases, federal courts in the Ninth Circuit rejected plaintiffs’ claims that alleged "bundling" practices violated the antitrust laws


Third Circuit Court of Appeals joins other Circuits in applying Daubert to expert testimony at class certification
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • April 13 2015

On April 8, the United States Court of Appeals for the Third Circuit issued an opinion vacating class certification in an antitrust case and holding


Fifth Circuit reverses jury verdict for antitrust plaintiffs, finding lack of sufficient evidence to establish a conspiracy
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 23 2015

The United States Court of Appeals for the Fifth Circuit recently reversed a jury verdict of liability under Sections 1 and 2 of the Sherman Act


FTC announces new Hart-Scott-Rodino and Clayton Act Section 8 thresholds
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 21 2015

The Federal Trade Commission (the "FTC") has revised the jurisdictional and filing fee thresholds of the Hart-Scott-Rodino Antitrust Improvements Act


Hart-Scott-Rodino enforcement: executive equity awards can trigger HSR filing obligations
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • January 6 2012

The Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR Act”) requires parties intending to acquire voting securities, assets or certain non-corporate interests to notify the Federal Trade Commission (“FTC”) and the Department of Justice, Antitrust Division (“DOJ”), and to observe certain waiting periods, if the HSR filing thresholds are met


Second Circuit applies rule of reason to uphold preliminary injunction preventing manufacturer from removing Alzheimer’s drug from market
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • June 3 2015

In State of New York v. Actavis plc, No. 14-4624-cv (2d Cir. May 22, 2015), the United States Court of Appeals for the Second Circuit addressed "a


Court of Appeals upholds decision unwinding consummated merger of two physician groups following FTC suit
  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • USA
  • February 17 2015

The United States Court of Appeals for the Ninth Circuit on February 10, 2015 issued an opinion in a closely-watched case in which it upheld a lower